Adalimumab-ryvk
NDC 82009-158, adalimumab-ryvk, kit, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-158
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761299
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-158-22 | 82009015822 | 2 KIT in 1 CARTON (82009-158-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-159-11) / .4 mL in 1 SYRINGE * .4 mL in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/dce1590f-9e47-4c4d-9437-cfb18b779a75
Use it
Look up 82009-158 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-158. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.